Dr. Éric Turcotte, MD
Claim this profileCentre de recherche du CHUS
Affiliated Hospitals
Centre De Recherche Du CHUS
CHUS
Clinical Trials Éric Turcotte, MD is currently running
Afternoon vs Morning Exercise
for Prediabetes
Exercise is well-known to improve skeletal muscle energy metabolism and is an established intervention to improve muscle insulin sensitivity and to counter the development of type 2 diabetes (T2D). However, given the 24h rhythmicity in substrate metabolism previously observed in healthy, lean men and the lack of such rhythmicity in men with insulin-resistance, the investigator hypothesize that appropriate timing of exercise training can maximize the metabolic health effects of exercise. Indeed, a preliminary study in humans revealed that afternoon high-intensity interval training (HIIT) exercise was more effective than morning exercise in improving 24h blood glucose levels in men with T2D. Another recent study in mice showed that the time of day is a critical factor in augmenting the beneficial effects of exercise on the skeletal muscle metabolome as well as on whole-body energy homeostasis. However, human studies that specifically target the impact of timing of exercise training on glucose homeostasis and metabolic health are scarce and the potential underlying mechanisms largely unknown. The overarching goals of this project is to improve 24-hour rhythmicity of metabolism in men and women with prediabtes by appropriate timing of exercise and to assess its effect on metabolic health and immune response. Acute and prolonged exercise interventions timed in the morning vs late afternoon will be carried out in individuals with prediabetes to determine whether acute exercise in the afternoon and prolonged exercise training in the afternoon can improve peripheral insulin sensitivity, compared to exercise in the morning, and positively affect adipose tissue dietary fatty acid storage and partitioning of dietary fatty acids in skeletal muscles.
Recruiting
1 award
N/A
4 criteria
68Ga-DOTA-TATE Imaging
for Neuroendocrine Cancer
This clinical trial is a pragmatic study aiming to evaluate the innocuity/safety profile of the PET radiotracer 68Ga-DOTA-TATE, and to establish the procedure as a routine standard-of-care diagnostic tool for all neuro-endocrine cancer patients. It is a single-center study, but with recruitment across all Canada. The trial is prospective, non-randomized, open-label and with no control group. The superiority of this procedure over the former standard-of-care (Octreoscan) was already established in previous and numerous studies across the world. As such, the current trial aims to gather data to further support the implementation of 68Ga-DOTA-TATE as the new standard-of-care for neuro-endocrine tumors (NET).
Recruiting
2 awards
Phase 3
3 criteria
More about Éric Turcotte, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Éric Turcotte, MD has experience with
- 18F-sodium Fluoride
- 68Ga-DOTA-TATE
- 4FMFES
- [111In]-FPI-2107
- [225Ac]-FPI-2068
- FPI-2053
Breakdown of trials Éric Turcotte, MD has run
Bone Disease
Bone Cancer
Rotator Cuff Arthropathy
Infections
Infectious Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Éric Turcotte, MD specialize in?
Éric Turcotte, MD focuses on Bone Disease and Bone Cancer. In particular, much of their work with Bone Disease has involved treating patients, or patients who are undergoing treatment.
Is Éric Turcotte, MD currently recruiting for clinical trials?
Yes, Éric Turcotte, MD is currently recruiting for 2 clinical trials in Sherbrooke Quebec. If you're interested in participating, you should apply.
Are there any treatments that Éric Turcotte, MD has studied deeply?
Yes, Éric Turcotte, MD has studied treatments such as 18F-sodium fluoride, 68Ga-DOTA-TATE, 4FMFES.
What is the best way to schedule an appointment with Éric Turcotte, MD?
Apply for one of the trials that Éric Turcotte, MD is conducting.
What is the office address of Éric Turcotte, MD?
The office of Éric Turcotte, MD is located at: Centre de recherche du CHUS, Sherbrooke, Quebec J1H 5N4 Canada. This is the address for their practice at the Centre de recherche du CHUS.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.